XiFin Research Identifies Millions in Recoverable Revenue for Ancillary Healthcare Providers — XiFin, Inc.

Event summary

XiFin and Sage Growth Partners released research quantifying $870,000 in annual recoverable revenue for mid-sized pathology practices and $2.6M for radiology practices.
The research identifies three interconnected dimensions of revenue cycle opportunity: Revenue Recovery, Operational Efficiency, and Patient Engagement and Access.
XiFin introduced the RCM Opportunity Explorer, an interactive tool to help providers estimate recoverable revenue.
The research was based on stakeholder interviews, industry data, and segment-specific reimbursement data.
XiFin will host a webinar on September 1, 2026, to discuss the findings.

The big picture

The research highlights the growing complexity of healthcare reimbursement and the need for AI-driven solutions to optimize revenue cycles. As regulatory pressures like the No Surprises Act increase, healthcare providers are looking for ways to reduce administrative burden and improve financial performance. XiFin's findings suggest that significant revenue opportunities exist for providers willing to invest in targeted improvements and AI-enabled workflows.

What we're watching

AI Adoption: How XiFin's AI-driven solutions will affect the pace of automation adoption in revenue cycle management.
Regulatory Compliance: Whether healthcare organizations can sustain compliance with the No Surprises Act while improving revenue cycle performance.
Market Expansion: The pace at which XiFin can expand its RCM Opportunity Explorer tool to other healthcare service lines.